• menu
    Market Place Market Place
    Sourcing support Sourcing Support
    API / FDF
    Excipients
    Services
    Developments
    News
    Market Intel
    #Phispers
    #SpeakPharma
    #LearnMore

    NEWS

    DRUGS & DEVELOPMENTS

    MARKET INTEL by PharmaCompass

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.
    All News #Library
    Others

    AB2 Bio sign agreement with Nippon for for ultra-rare disease

    GLOBENEWSWIRE

    NS Pharma`s Galactic53 Trial Data Is Published in Scientific Reports

    PR NEWSWIRE

    Capricor sells Europe rights to DMD therapy for $35M FDA application approaches

    FIERCE BIOTECH

    MiNA Collaboration with Nippon to Develop RNAa Therapeutics Targeting

    BUSINESSWIRE

    Japanese pharma firm Eli Lilly, Nippon Shinyaku join hands haematologic oncology

    BIOSPECTRUM ASIA

    Japan approves iron deficiency drug from Pharmacosmos

    MEDWATCH

    Nippon Shinyaku Establishes a Local Subsidiary in Tianjin, China

    PRESS RELEASE

    Capricor Tx, Nippon Shinyaku Partner for CAP-1002 in DMD

    GLOBENEWSWIRE

    Nippon Shinyaku, Dynacure partner to develop & commercialize DYN101 in Japan

    PHARMABIZ

    Menarini Group and Nippon Shinyaku Enter into an Exclusive License Agreement

    PRNEWSWIRE

    Nippon Shinyaku’s DMD Drug Gets Orphan Status in Europe

    JIHO

    Nippon Shinyaku inks new agreement for prostate cancer treatment

    BIOSPECTRUMASIA

    Chugai, Nippon Shinyaku bring Gazyva in Japan

    BIOSPECTRUM

    Copyright © 2026 LePro PharmaCompass OPC Private Limited, All rights reserved.